Semipermeable Cell Encapsulation Device with Collapsible Membranes

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Implantable medical devices for encapsulating insulin-producing cells face challenges in providing sufficient oxygen and nutrients to keep cells healthy and alive, and are associated with risks and traumas from invasive surgery.

Innovation Solution

An implantable cell encapsulation device with semipermeable membranes and weld lines that define cell channels, allowing for minimally invasive implantation in a collapsed configuration, which can be inflated to encase cells and promote oxygen and nutrient flow while preventing immune system interaction.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If traditional implantable encapsulation devices are used, then cell encapsulation is achieved, but surgical trauma and implantation risks increase due to invasive surgery requirements

Engineering Contradiction:
Improvecell encapsulation effectivenessVSAvoidsurgical trauma
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The device transitions from a collapsed delivery configuration to an expanded functional configuration after implantation. The membranes are initially compressed to fit through small incisions, then expand in situ to provide sufficient surface area for cell encapsulation and nutrient exchange, eliminating the need for large incisions while maintaining encapsulation effectiveness

Inventive Principle:
Principle #15Dynamics

Solution Approach 2:

The device is delivered in a nested, collapsed state within a catheter or delivery system, then deployed to expand into its functional form at the implantation site. This allows minimally invasive insertion followed by expansion to the required size for effective cell encapsulation

Inventive Principle:
Principle #7Nested doll (Nesting)

2Reliability

If sufficient cell sustaining materials are provided, then cell health and insulin production improve, but device complexity and manufacturing difficulty increase

Engineering Contradiction:
Improvecell health and insulin productionVSAvoiddevice structure
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The device employs porous or semipermeable membranes that naturally allow diffusion of oxygen, nutrients, and waste products. The porosity is engineered to provide adequate material exchange without requiring complex internal structures, channels, or active pumping systems, thus maintaining cell health while limiting device complexity

Inventive Principle:
Principle #31Porous materials

Solution Approach 2:

The membrane structure itself provides the cell sustaining function through passive diffusion. The material exchange occurs automatically based on concentration gradients, eliminating the need for complex active transport systems, pumps, or control mechanisms while ensuring adequate oxygen and nutrient supply to encapsulated cells

Inventive Principle:
Principle #25Self-service

3Reliability

If membrane surface area is increased to improve nutrient exchange, then cell sustenance improves, but device volume and implantation difficulty increase

Engineering Contradiction:
Improvenutrient exchange efficiencyVSAvoiddevice volume
Core Design Contradiction:
ReliabilityVSVolume of moving object

Solution Approach 1:

The device is delivered in a collapsed state with minimal volume to facilitate easy implantation through minimally invasive procedures, then expands in situ to provide large membrane surface area for efficient nutrient exchange. This dynamic transformation allows both small delivery volume and large functional surface area

Inventive Principle:
Principle #15Dynamics

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The device enhances cell survival by ensuring adequate oxygen and nutrient supply and reduces surgical trauma through minimally invasive implantation, promoting vascularization and efficient insulin production.

Implementation Method 1

Each of the cell encapsulation layers includes a first membrane that is semipermeable, a second membrane that is semipermeable

Methodology Applied
Scientific EffectSemipermeable membrane: Semipermeable Membrane

Data Source

PatentEP3600145B1Cell encapsulation device
Publication Date: 2024.06.26 BOSTON SCI MEDICAL DEVICE LTD
  • EP3600145B1 patent drawingFigure 1
  • EP3600145B1 patent drawingFigure 2~3
  • EP3600145B1 patent drawingFigure 4~5

AI summary

An implantable device for encapsulating cells includes one or more cell encapsulation layers. Each of the cell encapsulation layers includes a first membrane that is semipermeable, a second membrane that is semipermeable, and a first plurality of weld lines. The second membrane is attached to the first membrane by the first plurality of weld lines. The first membrane, the second membrane, and the first plurality of weld lines define at least one cell channel for encapsulating cells. The cell encapsulation device is configurable between a collapsed configuration and an inflated configuration.